CHA Biotech Co. Ltd Financial Flexibility Index
CHA Biotech Co. Ltd financial flexibility index. CHA Biotech Co. Ltd (085660) has a Financial Flexibility Index of 0.02x as of June 2026. Free cash flow of ₩39.73 Billion (operating CF ₩-208.26 Million minus capex ₩39.94 Billion) represents 0% of total liabilities (₩1.83 Trillion). Explore CHA Biotech Co. Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CHA Biotech Co. Ltd (2009–2025)
Financial flexibility index of CHA Biotech Co. Ltd from 2009 to 2025. Historical Financial Flexibility Index trend for CHA Biotech Co. Ltd across 17 annual periods. Check total reinvestment intensity of CHA Biotech Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
CHA Biotech Co. Ltd Financial Flexibility Index by Year (2009–2025)
CHA Biotech Co. Ltd financial flexibility index by year from 2009 to 2025. Year-by-year free cash flow to debt coverage for CHA Biotech Co. Ltd. For the full cash flow conversion analysis, see CHA Biotech Co. Ltd (085660) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | ₩79.54 Billion | ₩-72.52 Billion | ₩1.74 Trillion | ▲ +78.5% |
| 2024 | 0.03x | ₩48.96 Billion | ₩-49.55 Billion | ₩1.91 Trillion | ▼ -68.1% |
| 2023 | 0.08x | ₩85.89 Billion | ₩11.51 Billion | ₩1.07 Trillion | ▼ -2.4% |
| 2022 | 0.08x | ₩108.24 Billion | ₩-20.63 Billion | ₩1.32 Trillion | ▼ -35.5% |
| 2021 | 0.13x | ₩137.68 Billion | ₩22.23 Billion | ₩1.08 Trillion | ▼ -29.4% |
| 2020 | 0.18x | ₩173.22 Billion | ₩47.00 Billion | ₩958.62 Billion | ▲ +6.7% |
| 2019 | 0.17x | ₩133.01 Billion | ₩25.24 Billion | ₩785.74 Billion | ▼ -31.6% |
| 2018 | 0.25x | ₩153.52 Billion | ₩75.38 Billion | ₩620.54 Billion | ▲ +184.7% |
| 2017 | 0.09x | ₩48.92 Billion | ₩12.01 Billion | ₩562.87 Billion | ▼ -7.7% |
| 2016 | 0.09x | ₩45.42 Billion | ₩11.29 Billion | ₩482.61 Billion | ▼ -64.2% |
| 2015 | 0.26x | ₩93.22 Billion | ₩61.86 Billion | ₩354.73 Billion | ▲ +13.0% |
| 2014 | 0.23x | ₩42.67 Billion | ₩-2.57 Billion | ₩183.43 Billion | ▼ -57.3% |
| 2013 | 0.54x | ₩94.21 Billion | ₩66.35 Billion | ₩173.12 Billion | ▲ +32.9% |
| 2012 | 0.41x | ₩76.61 Billion | ₩45.77 Billion | ₩187.06 Billion | ▲ +29.0% |
| 2011 | 0.32x | ₩60.17 Billion | ₩34.69 Billion | ₩189.56 Billion | ▼ -17.0% |
| 2010 | 0.38x | ₩67.29 Billion | ₩42.07 Billion | ₩176.06 Billion | ▼ -6.4% |
| 2009 | 0.41x | ₩41.95 Billion | ₩24.02 Billion | ₩102.75 Billion | — |